Concepedia

Susan B. Manoff

SB

Statistics

Publications

11

Citations

693

H-Index

10

Active since

1989

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Michael E. DeBakey VA Medical Center

Johns Hopkins University

United States Military Academy

Susan B. Manoff is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, epidemiology, and vaccination.

Top concepts

Publications per year

1989–2018

11

Publications

11

Safety and Antibody Response, Including Antibody Persistence for 5 Years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle‐Aged and Older Adults

Daniel M. Musher, Susan B. Manoff, Charlie Liss et al. · The Journal of Infectious Diseases · 2010 · 155 citations · Full text

Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults

Daniel M. Musher, Susan B. Manoff, Richard McFetridge et al. · Human Vaccines · 2011 · 79 citations

, , +17

Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised Adults

Kathleen M. Mullane, Drew J. Winston, M. S. Wertheim et al. · The Journal of Infectious Diseases · 2013 · 78 citations · Full text

A real‐time PCR assay to identify and discriminate among wild‐type and vaccine strains of varicella‐zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses

Ruth Harbecke, Michael N. Oxman, Beth Arnold et al. · Journal of Medical Virology · 2009 · 71 citations

Revaccination with a 23‐Valent Pneumococcal Polysaccharide Vaccine Induces Elevated and Persistent Functional Antibody Responses in Adults Aged ⩾65 Years

Susan B. Manoff, Charles Liss, Michael J. Caulfield et al. · The Journal of Infectious Diseases · 2010 · 70 citations · Full text

1–5 of 11